DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
- 专利权人:
- Novartis AG
- 发明人:
- 申请号：
- NO2020017
- 公开号：
- NO2020017I1
- 申请日:
- 2020.06.17
- 申请国别(地区):
- NO
- 年份:
- 2020
- 代理人:
- 摘要：
- S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
- 来源网站：
- 中国工程科技知识中心
